Analyzing NovaBay Pharmaceuticals' Q4 GAAP EPS and Revenue Performance
Tuesday, 26 March 2024, 21:03
NovaBay Pharmaceuticals Q4 Earnings Report
NovaBay Pharmaceuticals recently disclosed their financial results for the fourth quarter, which included a GAAP EPS of -$1.33 and revenue of $3.7M, marking a 2.8% increase from the previous year.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.